TSH BIOPHARM CORPORATION LTD.
Update:2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
Prescription medication -
1. Cardiovascular
2. Central Nervous
3. Gastrointestinal
4. Others
1. AlphaLiquid® Detect
2. AlphaLiquid®
3. AlphaLiquid®
4. AlphaSolid®
5. Lung Cancer Panel
6. UNITED™
7. Prosigna®
1. Cardiovascular
2. Central Nervous
3. Gastrointestinal
4. Others
1. AlphaLiquid® Detect
2. AlphaLiquid®
3. AlphaLiquid®
4. AlphaSolid®
5. Lung Cancer Panel
6. UNITED™
7. Prosigna®
The content above was translated by Ai
Founded Year
2010
Unified Business No.
53093421
Status
Active
Number of Employees
0
Total Paid-in
Capital
383,981,400 (NT$)
Location of Company
Taiwan
, Taipei City
Exit Status
OTC listing(2012)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Dongshenghua is committed to the development of cardiovascular and autoimmune diseases with economic benefits and high barriers, and to provide comprehensive testing services for human genetic testing, liquid cell and genetic testing of cancer patients.
The content above was translated by Ai